Aishwarya Sundaram
Overview
Explore the profile of Aishwarya Sundaram including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sundaram A, Subramaniam H, Ab Hamid S, Nor A
PeerJ
. 2024 Apr;
12:e17133.
PMID: 38563009
Background: In the current era of rapid technological innovation, our lives are becoming more closely intertwined with digital systems. Consequently, every human action generates a valuable repository of digital data....
2.
Ruparelia S, Sundaram A, Dahrab M, Symonds C, Cruess A
Cureus
. 2022 Jan;
13(12):e20195.
PMID: 35004017
Choroidal neovascularization (CNV) is a rare condition in children but poses a substantial threat to vision. Anti-vascular endothelial growth factor (anti-VEGF) therapy is commonly used in the pediatric population to...
3.
Benson M, Donaldson L, Mercer G, Qian J, Sundaram A
Can J Ophthalmol
. 2020 Feb;
55(1):e1-e6.
PMID: 32085859
No abstract available.
4.
Sharafeldin N, Kawaguchi A, Sundaram A, Campbell S, Rudnisky C, Weis E, et al.
Br J Ophthalmol
. 2018 Apr;
102(11):1485-1491.
PMID: 29680803
Background/aims: Teleophthalmology is well positioned to play a key role in screening of major chronic eye diseases. Economic evaluation of cost-effectiveness of teleophthalmology, however, is lacking. This study provides a...
5.
Kawaguchi A, Sharafeldin N, Sundaram A, Campbell S, Tennant M, Rudnisky C, et al.
Telemed J E Health
. 2017 Aug;
24(4):301-308.
PMID: 28783458
Background: To synthesize high-quality evidence to compare traditional in-person screening and tele-ophthalmology screening. Methods: Only randomized controlled trials (RCTs) were included in this systematic review and meta-analysis. The intervention of...
6.
Sancenon V, Goh W, Sundaram A, Er K, Johal N, Mukhina S, et al.
Biomol Detect Quantif
. 2016 Apr;
4:1-9.
PMID: 27077032
The successful discovery and subsequent development of small molecule inhibitors of drug targets relies on the establishment of robust, cost-effective, quantitative, and physiologically relevant in vitro assays that can support...
7.
Stoy C, Sundaram A, Garcia M, Wang X, Seibert O, Zota A, et al.
EMBO Mol Med
. 2015 Jun;
7(8):1048-62.
PMID: 26070712
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer fatalities in Western societies, characterized by high metastatic potential and resistance to chemotherapy. Critical molecular mechanisms of these phenotypical...
8.
Humnabadkar V, Madhavapeddi P, Basavarajappa H, Sheikh M, Rane R, Basu R, et al.
J Biomol Screen
. 2014 Oct;
20(2):265-74.
PMID: 25300873
Mycobacterium tuberculosis (Mtb) DNA gyrase ATPase was the target of a tuberculosis drug discovery program. The low specific activity of the Mtb ATPase prompted the use of Mycobacterium smegmatis (Msm)...
9.
Reddy B, Landge S, Ravishankar S, Patil V, Shinde V, Tantry S, et al.
Antimicrob Agents Chemother
. 2014 Apr;
58(6):3312-26.
PMID: 24687493
Pantothenate kinase (PanK) catalyzes the phosphorylation of pantothenate, the first committed and rate-limiting step toward coenzyme A (CoA) biosynthesis. In our earlier reports, we had established that the type I...